[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

COVID-19 Impact on Global Brimonidine Market Size, Status and Forecast 2020-2026

July 2020 | 91 pages | ID: CDB6CE3D3BCFEN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report focuses on the global Brimonidine status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Brimonidine development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
  • Allergan
  • Physicians Total Care
  • Pharmascience
  • Aa Pharma
  • Novartis
  • Galderma
  • Akorn
  • Apotex Corporation
  • Pacific Pharma
  • Osmotica Pharmaceutical
  • Somerset Therapeutics
  • Teva Pharmaceutical Industries
Market segment by Type, the product can be split into
  • Oral
  • Eye Drops
Market segment by Application, split into
  • Open-angle Glaucoma
  • High Intraocular Pressure
  • Others
Market segment by Regions/Countries, this report covers
  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
  • Central & South America
The study objectives of this report are:
  • To analyze global Brimonidine status, future forecast, growth opportunity, key market and key players.
  • To present the Brimonidine development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
  • To strategically profile the key players and comprehensively analyze their development plan and strategies.
  • To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Brimonidine are as follows:
  • History Year: 2015-2019
  • Base Year: 2019
  • Estimated Year: 2020
  • Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Brimonidine Revenue
1.4 Market Analysis by Type
  1.4.1 Global Brimonidine Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Oral
  1.4.3 Eye Drops
1.5 Market by Application
  1.5.1 Global Brimonidine Market Share by Application: 2020 VS 2026
  1.5.2 Open-angle Glaucoma
  1.5.3 High Intraocular Pressure
  1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Brimonidine Industry Impact
  1.6.1 How the Covid-19 is Affecting the Brimonidine Industry
    1.6.1.1 Brimonidine Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Brimonidine Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Brimonidine Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Brimonidine Market Perspective (2015-2026)
2.2 Brimonidine Growth Trends by Regions
  2.2.1 Brimonidine Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Brimonidine Historic Market Share by Regions (2015-2020)
  2.2.3 Brimonidine Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Brimonidine Market Growth Strategy
  2.3.6 Primary Interviews with Key Brimonidine Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Brimonidine Players by Market Size
  3.1.1 Global Top Brimonidine Players by Revenue (2015-2020)
  3.1.2 Global Brimonidine Revenue Market Share by Players (2015-2020)
  3.1.3 Global Brimonidine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Brimonidine Market Concentration Ratio
  3.2.1 Global Brimonidine Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Brimonidine Revenue in 2019
3.3 Brimonidine Key Players Head office and Area Served
3.4 Key Players Brimonidine Product Solution and Service
3.5 Date of Enter into Brimonidine Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Brimonidine Historic Market Size by Type (2015-2020)
4.2 Global Brimonidine Forecasted Market Size by Type (2021-2026)

5 BRIMONIDINE BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Brimonidine Market Size by Application (2015-2020)
5.2 Global Brimonidine Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Brimonidine Market Size (2015-2020)
6.2 Brimonidine Key Players in North America (2019-2020)
6.3 North America Brimonidine Market Size by Type (2015-2020)
6.4 North America Brimonidine Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Brimonidine Market Size (2015-2020)
7.2 Brimonidine Key Players in Europe (2019-2020)
7.3 Europe Brimonidine Market Size by Type (2015-2020)
7.4 Europe Brimonidine Market Size by Application (2015-2020)

8 CHINA

8.1 China Brimonidine Market Size (2015-2020)
8.2 Brimonidine Key Players in China (2019-2020)
8.3 China Brimonidine Market Size by Type (2015-2020)
8.4 China Brimonidine Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Brimonidine Market Size (2015-2020)
9.2 Brimonidine Key Players in Japan (2019-2020)
9.3 Japan Brimonidine Market Size by Type (2015-2020)
9.4 Japan Brimonidine Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Brimonidine Market Size (2015-2020)
10.2 Brimonidine Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Brimonidine Market Size by Type (2015-2020)
10.4 Southeast Asia Brimonidine Market Size by Application (2015-2020)

11 INDIA

11.1 India Brimonidine Market Size (2015-2020)
11.2 Brimonidine Key Players in India (2019-2020)
11.3 India Brimonidine Market Size by Type (2015-2020)
11.4 India Brimonidine Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Brimonidine Market Size (2015-2020)
12.2 Brimonidine Key Players in Central & South America (2019-2020)
12.3 Central & South America Brimonidine Market Size by Type (2015-2020)
12.4 Central & South America Brimonidine Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Allergan
  13.1.1 Allergan Company Details
  13.1.2 Allergan Business Overview and Its Total Revenue
  13.1.3 Allergan Brimonidine Introduction
  13.1.4 Allergan Revenue in Brimonidine Business (2015-2020))
  13.1.5 Allergan Recent Development
13.2 Physicians Total Care
  13.2.1 Physicians Total Care Company Details
  13.2.2 Physicians Total Care Business Overview and Its Total Revenue
  13.2.3 Physicians Total Care Brimonidine Introduction
  13.2.4 Physicians Total Care Revenue in Brimonidine Business (2015-2020)
  13.2.5 Physicians Total Care Recent Development
13.3 Pharmascience
  13.3.1 Pharmascience Company Details
  13.3.2 Pharmascience Business Overview and Its Total Revenue
  13.3.3 Pharmascience Brimonidine Introduction
  13.3.4 Pharmascience Revenue in Brimonidine Business (2015-2020)
  13.3.5 Pharmascience Recent Development
13.4 Aa Pharma
  13.4.1 Aa Pharma Company Details
  13.4.2 Aa Pharma Business Overview and Its Total Revenue
  13.4.3 Aa Pharma Brimonidine Introduction
  13.4.4 Aa Pharma Revenue in Brimonidine Business (2015-2020)
  13.4.5 Aa Pharma Recent Development
13.5 Novartis
  13.5.1 Novartis Company Details
  13.5.2 Novartis Business Overview and Its Total Revenue
  13.5.3 Novartis Brimonidine Introduction
  13.5.4 Novartis Revenue in Brimonidine Business (2015-2020)
  13.5.5 Novartis Recent Development
13.6 Galderma
  13.6.1 Galderma Company Details
  13.6.2 Galderma Business Overview and Its Total Revenue
  13.6.3 Galderma Brimonidine Introduction
  13.6.4 Galderma Revenue in Brimonidine Business (2015-2020)
  13.6.5 Galderma Recent Development
13.7 Akorn
  13.7.1 Akorn Company Details
  13.7.2 Akorn Business Overview and Its Total Revenue
  13.7.3 Akorn Brimonidine Introduction
  13.7.4 Akorn Revenue in Brimonidine Business (2015-2020)
  13.7.5 Akorn Recent Development
13.8 Apotex Corporation
  13.8.1 Apotex Corporation Company Details
  13.8.2 Apotex Corporation Business Overview and Its Total Revenue
  13.8.3 Apotex Corporation Brimonidine Introduction
  13.8.4 Apotex Corporation Revenue in Brimonidine Business (2015-2020)
  13.8.5 Apotex Corporation Recent Development
13.9 Pacific Pharma
  13.9.1 Pacific Pharma Company Details
  13.9.2 Pacific Pharma Business Overview and Its Total Revenue
  13.9.3 Pacific Pharma Brimonidine Introduction
  13.9.4 Pacific Pharma Revenue in Brimonidine Business (2015-2020)
  13.9.5 Pacific Pharma Recent Development
13.10 Osmotica Pharmaceutical
  13.10.1 Osmotica Pharmaceutical Company Details
  13.10.2 Osmotica Pharmaceutical Business Overview and Its Total Revenue
  13.10.3 Osmotica Pharmaceutical Brimonidine Introduction
  13.10.4 Osmotica Pharmaceutical Revenue in Brimonidine Business (2015-2020)
  13.10.5 Osmotica Pharmaceutical Recent Development
13.11 Somerset Therapeutics
  10.11.1 Somerset Therapeutics Company Details
  10.11.2 Somerset Therapeutics Business Overview and Its Total Revenue
  10.11.3 Somerset Therapeutics Brimonidine Introduction
  10.11.4 Somerset Therapeutics Revenue in Brimonidine Business (2015-2020)
  10.11.5 Somerset Therapeutics Recent Development
13.12 Teva Pharmaceutical Industries
  10.12.1 Teva Pharmaceutical Industries Company Details
  10.12.2 Teva Pharmaceutical Industries Business Overview and Its Total Revenue
  10.12.3 Teva Pharmaceutical Industries Brimonidine Introduction
  10.12.4 Teva Pharmaceutical Industries Revenue in Brimonidine Business (2015-2020)
  10.12.5 Teva Pharmaceutical Industries Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

LIST OF TABLES

Table 1. Brimonidine Key Market Segments
Table 2. Key Players Covered: Ranking by Brimonidine Revenue
Table 3. Ranking of Global Top Brimonidine Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Brimonidine Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Oral
Table 6. Key Players of Eye Drops
Table 7. COVID-19 Impact Global Market: (Four Brimonidine Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Brimonidine Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Brimonidine Players to Combat Covid-19 Impact
Table 12. Global Brimonidine Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Brimonidine Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Brimonidine Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Brimonidine Market Share by Regions (2015-2020)
Table 16. Global Brimonidine Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Brimonidine Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Brimonidine Market Growth Strategy
Table 22. Main Points Interviewed from Key Brimonidine Players
Table 23. Global Brimonidine Revenue by Players (2015-2020) (Million US$)
Table 24. Global Brimonidine Market Share by Players (2015-2020)
Table 25. Global Top Brimonidine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Brimonidine as of 2019)
Table 26. Global Brimonidine by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Brimonidine Product Solution and Service
Table 29. Date of Enter into Brimonidine Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Brimonidine Market Size by Type (2015-2020) (Million US$)
Table 32. Global Brimonidine Market Size Share by Type (2015-2020)
Table 33. Global Brimonidine Revenue Market Share by Type (2021-2026)
Table 34. Global Brimonidine Market Size Share by Application (2015-2020)
Table 35. Global Brimonidine Market Size by Application (2015-2020) (Million US$)
Table 36. Global Brimonidine Market Size Share by Application (2021-2026)
Table 37. North America Key Players Brimonidine Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Brimonidine Market Share (2019-2020)
Table 39. North America Brimonidine Market Size by Type (2015-2020) (Million US$)
Table 40. North America Brimonidine Market Share by Type (2015-2020)
Table 41. North America Brimonidine Market Size by Application (2015-2020) (Million US$)
Table 42. North America Brimonidine Market Share by Application (2015-2020)
Table 43. Europe Key Players Brimonidine Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Brimonidine Market Share (2019-2020)
Table 45. Europe Brimonidine Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Brimonidine Market Share by Type (2015-2020)
Table 47. Europe Brimonidine Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Brimonidine Market Share by Application (2015-2020)
Table 49. China Key Players Brimonidine Revenue (2019-2020) (Million US$)
Table 50. China Key Players Brimonidine Market Share (2019-2020)
Table 51. China Brimonidine Market Size by Type (2015-2020) (Million US$)
Table 52. China Brimonidine Market Share by Type (2015-2020)
Table 53. China Brimonidine Market Size by Application (2015-2020) (Million US$)
Table 54. China Brimonidine Market Share by Application (2015-2020)
Table 55. Japan Key Players Brimonidine Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Brimonidine Market Share (2019-2020)
Table 57. Japan Brimonidine Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Brimonidine Market Share by Type (2015-2020)
Table 59. Japan Brimonidine Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Brimonidine Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Brimonidine Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Brimonidine Market Share (2019-2020)
Table 63. Southeast Asia Brimonidine Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Brimonidine Market Share by Type (2015-2020)
Table 65. Southeast Asia Brimonidine Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Brimonidine Market Share by Application (2015-2020)
Table 67. India Key Players Brimonidine Revenue (2019-2020) (Million US$)
Table 68. India Key Players Brimonidine Market Share (2019-2020)
Table 69. India Brimonidine Market Size by Type (2015-2020) (Million US$)
Table 70. India Brimonidine Market Share by Type (2015-2020)
Table 71. India Brimonidine Market Size by Application (2015-2020) (Million US$)
Table 72. India Brimonidine Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Brimonidine Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Brimonidine Market Share (2019-2020)
Table 75. Central & South America Brimonidine Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Brimonidine Market Share by Type (2015-2020)
Table 77. Central & South America Brimonidine Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Brimonidine Market Share by Application (2015-2020)
Table 79. Allergan Company Details
Table 80. Allergan Business Overview
Table 81. Allergan Product
Table 82. Allergan Revenue in Brimonidine Business (2015-2020) (Million US$)
Table 83. Allergan Recent Development
Table 84. Physicians Total Care Company Details
Table 85. Physicians Total Care Business Overview
Table 86. Physicians Total Care Product
Table 87. Physicians Total Care Revenue in Brimonidine Business (2015-2020) (Million US$)
Table 88. Physicians Total Care Recent Development
Table 89. Pharmascience  Company Details
Table 90. Pharmascience  Business Overview
Table 91. Pharmascience  Product
Table 92. Pharmascience  Revenue in Brimonidine Business (2015-2020) (Million US$)
Table 93. Pharmascience  Recent Development
Table 94. Aa Pharma Company Details
Table 95. Aa Pharma Business Overview
Table 96. Aa Pharma Product
Table 97. Aa Pharma Revenue in Brimonidine Business (2015-2020) (Million US$)
Table 98. Aa Pharma Recent Development
Table 99. Novartis Company Details
Table 100. Novartis Business Overview
Table 101. Novartis Product
Table 102. Novartis Revenue in Brimonidine Business (2015-2020) (Million US$)
Table 103. Novartis Recent Development
Table 104. Galderma Company Details
Table 105. Galderma Business Overview
Table 106. Galderma Product
Table 107. Galderma Revenue in Brimonidine Business (2015-2020) (Million US$)
Table 108. Galderma Recent Development
Table 109. Akorn Company Details
Table 110. Akorn Business Overview
Table 111. Akorn Product
Table 112. Akorn Revenue in Brimonidine Business (2015-2020) (Million US$)
Table 113. Akorn Recent Development
Table 114. Apotex Corporation Business Overview
Table 115. Apotex Corporation Product
Table 116. Apotex Corporation Company Details
Table 117. Apotex Corporation Revenue in Brimonidine Business (2015-2020) (Million US$)
Table 118. Apotex Corporation Recent Development
Table 119. Pacific Pharma Company Details
Table 120. Pacific Pharma Business Overview
Table 121. Pacific Pharma Product
Table 122. Pacific Pharma Revenue in Brimonidine Business (2015-2020) (Million US$)
Table 123. Pacific Pharma Recent Development
Table 124. Osmotica Pharmaceutical  Company Details
Table 125. Osmotica Pharmaceutical  Business Overview
Table 126. Osmotica Pharmaceutical  Product
Table 127. Osmotica Pharmaceutical  Revenue in Brimonidine Business (2015-2020) (Million US$)
Table 128. Osmotica Pharmaceutical  Recent Development
Table 129. Somerset Therapeutics Company Details
Table 130. Somerset Therapeutics Business Overview
Table 131. Somerset Therapeutics Product
Table 132. Somerset Therapeutics Revenue in Brimonidine Business (2015-2020) (Million US$)
Table 133. Somerset Therapeutics Recent Development
Table 134. Teva Pharmaceutical Industries Company Details
Table 135. Teva Pharmaceutical Industries Business Overview
Table 136. Teva Pharmaceutical Industries Product
Table 137. Teva Pharmaceutical Industries Revenue in Brimonidine Business (2015-2020) (Million US$)
Table 138. Teva Pharmaceutical Industries Recent Development
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. Global Brimonidine Market Share by Type: 2020 VS 2026
Figure 2. Oral Features
Figure 3. Eye Drops Features
Figure 4. Global Brimonidine Market Share by Application: 2020 VS 2026
Figure 5. Open-angle Glaucoma Case Studies
Figure 6. High Intraocular Pressure Case Studies
Figure 7. Others Case Studies
Figure 8. Brimonidine Report Years Considered
Figure 9. Global Brimonidine Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Brimonidine Market Share by Regions: 2020 VS 2026
Figure 11. Global Brimonidine Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Brimonidine Market Share by Players in 2019
Figure 14. Global Top Brimonidine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Brimonidine as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Brimonidine Revenue in 2019
Figure 16. North America Brimonidine Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Brimonidine Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Brimonidine Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Brimonidine Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Brimonidine Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Brimonidine Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Brimonidine Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Allergan Revenue Growth Rate in Brimonidine Business (2015-2020)
Figure 25. Physicians Total Care Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Physicians Total Care Revenue Growth Rate in Brimonidine Business (2015-2020)
Figure 27. Pharmascience  Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Pharmascience  Revenue Growth Rate in Brimonidine Business (2015-2020)
Figure 29. Aa Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Aa Pharma Revenue Growth Rate in Brimonidine Business (2015-2020)
Figure 31. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Novartis Revenue Growth Rate in Brimonidine Business (2015-2020)
Figure 33. Galderma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Galderma Revenue Growth Rate in Brimonidine Business (2015-2020)
Figure 35. Akorn Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Akorn Revenue Growth Rate in Brimonidine Business (2015-2020)
Figure 37. Apotex Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Apotex Corporation Revenue Growth Rate in Brimonidine Business (2015-2020)
Figure 39. Pacific Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Pacific Pharma Revenue Growth Rate in Brimonidine Business (2015-2020)
Figure 41. Osmotica Pharmaceutical  Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Osmotica Pharmaceutical  Revenue Growth Rate in Brimonidine Business (2015-2020)
Figure 43. Somerset Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Somerset Therapeutics Revenue Growth Rate in Brimonidine Business (2015-2020)
Figure 45. Teva Pharmaceutical Industries Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Teva Pharmaceutical Industries Revenue Growth Rate in Brimonidine Business (2015-2020)
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed


More Publications